...
首页> 外文期刊>BMC Veterinary Research >Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model
【24h】

Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model

机译:使用直接接触传播模型的腺病毒载体口蹄疫病毒血清型A亚单位疫苗在牛中的功效

获取原文

摘要

A direct contact transmission challenge model was used to simulate natural foot-and-mouth disease virus (FMDV) spread from FMDV A24/Cruzeiro/BRA/55 infected ‘seeder’ steers to na?ve or vaccinated steers previously immunized with a replication-deficient human adenovirus-vectored FMDV A24/Cruzeiro/BRA/55 capsid-based subunit vaccine (AdtA24). In two independent vaccine efficacy trials, AdtA24 was administered once intramuscularly in the neck 7?days prior to contact with FMDV A24/Cruzeiro/BRA/55-infected seeder steers. In Efficacy Study 1, we evaluated three doses of AdtA24 to estimate the 50%/90% bovine protective dose (BPD50/90) for prevention of clinical FMD. In vaccinated, contact-challenged steers, the BPD50/90 was 3.1?×?1010 / 5.5?×?1010 AdtA24 particles formulated without adjuvant. In Efficacy Study 2, steers vaccinated with 5?×?1010 AdtA24 particles, exposed to FMDV A24/Cruzeiro/BRA/55-infected seeder steers, did not develop clinical FMD or transmit FMDV to other vaccinated or na?ve, non-vaccinated steers. In contrast, na?ve, non-vaccinated steers that were subsequently exposed to FMDV A24/Cruzeiro/BRA/55-infected seeder steers developed clinical FMD and transmitted FMDV by contact to additional na?ve, non-vaccinated steers. The AdtA24 vaccine differentiated infected from vaccinated animals (DIVA) because no antibodies to FMDV nonstructural proteins were detected prior to FMDV exposure. A single dose of the AdtA24 non-adjuvanted vaccine conferred protection against clinical FMD at 7?days post-vaccination following direct contact transmission from FMDV-infected, na?ve, non-vaccinated steers. The AdtA24 vaccine was effective in preventing FMDV transmission from homologous challenged, contact-exposed, AdtA24-vaccinated, protected steers to co-mingled, susceptible steers, suggesting that the vaccine may be beneficial in reducing both the magnitude and duration of a FMDV outbreak in a commercial cattle production setting.
机译:使用直接接触传播挑战模型来模拟从受FMDV A24 /克鲁塞罗/ BRA / 55感染的“播种者”公牛传播至未经复制缺陷免疫的幼稚或接种公牛的天然口蹄疫病毒(FMDV)人腺病毒载体的FMDV A24 / Cruzeiro / BRA / 55衣壳基亚单位疫苗(AdtA24)。在两项独立的疫苗功效试验中,在接触FMDV A24 / Cruzeiro / BRA / 55感染的播种ste牛之前7天,在颈部肌肉内一次注射AdtA24。在功效研究1中,我们评估了AdtA24的三种剂量,以评估50%/ 90%的牛保护剂量(BPD50 / 90)用于预防临床FMD。在接种的,接触挑战的ste牛皮中,BPD50 / 90为3.1?×?1010 / 5.5?×?1010不含佐剂的AdtA24颗粒。在功效研究2中,接种了FMDV A24 / Cruzeiro / BRA / 55感染的播种机,接种了5××1010 AdtA24颗粒的ste牛皮,未发展出临床FMD或将FMDV传播给其他已接种或未接种过的初免引导。相比之下,随后暴露于FMDV A24 / Cruzeiro / BRA / 55感染的播种机中的未经接种的纯天然ste牛发展出了临床口蹄疫,并通过与其他未经接种的未经接种的ers牛接触而传播了FMDV。 AdtA24疫苗将感染动物与疫苗接种动物(DIVA)区别开来,因为在FMDV暴露之前未检测到针对FMDV非结构蛋白的抗体。单剂量的AdtA24非佐剂疫苗可在接种后7天(经FMDV感染,未经疫苗接种的纯正ste牛直接接触传播)提供针对临床口蹄疫的保护。 AdtA24疫苗可有效预防FMDV传播,从同源挑战,接触,接种AdtA24,受保护的公牛到混杂的易感公牛,这表明该疫苗可能有利于减少FMDV暴发的程度和持续时间。商业牛的生产环境。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号